Zepp Health annual stock-based compensation
2017
2018
2019
2020
2021
2022
2023
2024
2025
Zepp Health Stock-Based Compensation Growth & History (ZEPP)
Zepp Health's stock-based compensation was $2.5M for fiscal 2025.
View full Zepp Health company overviewZepp Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.5M | −$2.3M | −47.84% |
| 2024 | 2024-12-31 | $4.8M | −$4.0M | −45.66% |
| 2023 | 2023-12-31 | $8.8M | $1.5M | +20.90% |
| 2022 | 2022-12-31 | $7.3M | −$5.8M | −44.25% |
| 2021 | 2021-12-31 | $13.0M | $3.1M | +30.64% |
| 2020 | 2020-12-31 | $10.0M | $2.1M | +26.11% |
| 2019 | 2019-12-31 | $7.9M | −$11.7M | −59.59% |
| 2018 | 2018-12-31 | $19.6M | $9.9M | +103.03% |
| 2017 | 2017-12-31 | $9.7M | — | — |
Zepp Health stock-based compensation trends
Over the last five fiscal years, Zepp Health's stock-based compensation decreased from $10.0M to $2.5M, a change of −$7.5M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zepp Health source filings ↗